Cyclosporine Capsules, Modified and Incruse Ellipta
Determining the interaction of Cyclosporine Capsules, Modified and Incruse Ellipta and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Cyclosporine (oral/injection), CycloSPORINE (Systemic)
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclosporine Capsules, Modified-Indacaterol
- Cyclosporine Capsules, Modified-Indacaterol and Glycopyrrolate
- Cyclosporine Capsules, Modified-Indacaterol and glycopyrrolate Inhalation
- Cyclosporine Capsules, Modified-Indacaterol inhalation
- Cyclosporine Capsules, Modified-Indacaterol Maleate
- Cyclosporine Capsules, Modified-Indapamide
- Incruse Ellipta-Cyclosporine Injection
- Incruse Ellipta-Cyclosporine Oral Solution
- Incruse Ellipta-Cyclosporine Oral Solution, Modified
- Incruse Ellipta-Cyclosporine Oral, Intravenous
- Incruse Ellipta-Cyclosporine oral/injection
- Incruse Ellipta-Cyclosporine Soft Gelatin Capsules